Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic Targets

Antonio Di Narzo(Cardiovascular Institute of the South), Carmen Argmann(Icahn School of Medicine at Mount Sinai), Ke Hao(Boston University), Eduard Rogatsky(Center for Information Technology), Joshua R. Friedman(Spark Therapeutics (United States)), Frédéric M. Vaz(Netherlands Metabolomics Centre), Judy H. Cho(Cedars-Sinai Medical Center), Jean‐Frédéric Colombel(Mount Sinai Hospital), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Marla C. Dubinsky(Icahn School of Medicine at Mount Sinai), Sander M. Houten(Icahn School of Medicine at Mount Sinai), Carrie Brodmerkel(Janssen (United States)), Andrew Kasarskis(Icahn School of Medicine at Mount Sinai), Ryan C. Ungaro(Feinstein Institute for Medical Research), Jacqueline Perrigoue(Johnson & Johnson (United States)), Ruiqi Huang(Icahn School of Medicine at Mount Sinai), Jun Zhu(China National Nuclear Corporation), Roman Kosoy(University of California, Davis), Phillip Comella(Center for Information Technology), Eric E. Schadt(Program for Appropriate Technology in Health), Mayte Suárez‐Fariñas(Rockefeller University), Tetyana Dodatko(Center for Information Technology), Aleksandar Stojmirović(Janssen (United States)), Wenhui Wang(Nanjing Medical University), Gabrielle Wei(Center for Information Technology), Amy Hart(Janssen (United States)), Manasi Agrawal(Aalborg University), Mark Curran(Janssen (United States)), Ruixue Hou(Icahn School of Medicine at Mount Sinai)
Gastroenterology
November 13, 2021
Cited by 87


Related Papers